President Biden’s proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump’s administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.
Related Posts
Severe weather storms forecast throughout South, Midwest; 3 dead in Texas
Tornadoes may hit the Mississippi Valley on Friday, as well as blizzards in the northern Plains and gusty conditions in…
Presidential candidates inject star power into campaigns with 10 days left until Election Day
With only 10 days left until Election Day, Beyoncé attended a Houston rally for Vice President Kamala Harris and former…
AOC loses bid to become top Democrat on Oversight Committee
Rep. Gerry Connolly of Virginia won election to serve as the top Democrat on the House Oversight Committee, defeating Rep.…